Amphastar Pharmaceuticals, Inc. Quarterly Operating Income (Loss) in USD from Q2 2013 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Amphastar Pharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2013 to Q4 2024.
  • Amphastar Pharmaceuticals, Inc. Operating Income (Loss) for the quarter ending December 31, 2024 was $45.1M, a 16.4% decline year-over-year.
  • Amphastar Pharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending December 31, 2024 was $205M, a 4.28% increase year-over-year.
  • Amphastar Pharmaceuticals, Inc. annual Operating Income (Loss) for 2024 was $205M, a 4.28% increase from 2023.
  • Amphastar Pharmaceuticals, Inc. annual Operating Income (Loss) for 2023 was $197M, a 83.2% increase from 2022.
  • Amphastar Pharmaceuticals, Inc. annual Operating Income (Loss) for 2022 was $107M, a 53.8% increase from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 $205M $45.1M -$8.84M -16.4% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-03
Q3 2024 $214M $57M -$15.6M -21.5% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $230M $55.2M +$18.3M +49.7% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-09
Q1 2024 $212M $48M +$14.6M +43.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $197M $54M +$16.1M +42.7% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-03
Q3 2023 $181M $72.7M +$49.5M +213% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $131M $36.9M +$12.1M +48.6% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-09
Q1 2023 $119M $33.4M +$11.8M +54.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 $107M $37.8M +$13.6M +56% Oct 1, 2022 Dec 31, 2022 10-K 2025-03-03
Q3 2022 $93.9M $23.2M -$1.54M -6.22% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 $95.5M $24.8M +$14.3M +135% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $81.2M $21.6M +$11.3M +110% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $69.9M $24.3M +$21.4M +742% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-29
Q3 2021 $48.5M $24.8M +$21.3M +604% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $27.3M $10.6M +$13.5M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $13.8M $10.3M +$2.83M +37.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $11M $2.88M +$3.12M Oct 1, 2020 Dec 31, 2020 10-K 2023-03-01
Q3 2020 $7.83M $3.52M +$1.11M +46.3% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $6.72M -$2.92M -$3.9M -400% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 $10.6M $7.48M +$10.7M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 -$39K -$244K -$1.79M -116% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-11
Q3 2019 $1.75M $2.4M -$146K -5.73% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 $1.9M $973K +$3.91M Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-07
Q1 2019 -$2.02M -$3.17M +$6.61M +67.6% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 -$8.62M $1.55M +$3.46M Oct 1, 2018 Dec 31, 2018 10-K 2021-03-15
Q3 2018 -$12.1M $2.55M +$5.49M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-08
Q2 2018 -$17.6M -$2.94M -$5.13M -235% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 -$12.5M -$9.78M -$11.2M -796% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 -$1.27M -$1.92M +$2.91M +60.3% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-16
Q3 2017 -$4.18M -$2.94M -$8.74M -151% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 $4.56M $2.19M -$8.15M -78.8% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 $12.7M $1.4M -$2.67M -65.5% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 $15.4M -$4.83M -$19.2M -134% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-15
Q3 2016 $34.6M $5.8M +$9.55M Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 $25M $10.3M +$20.6M Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 $4.44M $4.08M +$11.3M Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 -$6.9M $14.4M +$21.4M Oct 1, 2015 Dec 31, 2015 10-K 2018-03-14
Q3 2015 -$28.3M -$3.75M +$4.07M +52.1% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 -$32.4M -$10.3M -$9.09M -775% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 -$23.3M -$7.26M -$5.29M -269% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 -$18M -$7.03M Oct 1, 2014 Dec 31, 2014 10-K 2017-03-15
Q3 2014 -$7.82M -$8.04M -3559% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-13
Q2 2014 -$1.17M -$13.2M -110% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-13
Q1 2014 -$1.97M Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-14
Q3 2013 $226K Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-13
Q2 2013 $12M Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.